Janssen Products, LP
Records under this name other than the patents Janssen Products, LP holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 10 of 10 · Back to Janssen Products, LP
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,481,510 | Uracyl Spirooxetane Nucleosides Formerly held Lapsed on the fee record Ended Jul 9, 2025 · High confidence | Lapsed on the fee record | Ended Jul 9, 2025 | High confidence |
| US 7,825,239 | Antiviral nucleosides Lapsed on the fee record Ended Nov 2, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 2, 2022 | From the USPTO record |
| US 7,666,856 | Antiviral nucleosides Lapsed on the fee record Ended Feb 23, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 23, 2022 | From the USPTO record |
| US 8,552,021 | Phosphoramidate Derivatives of Nucleosides Formerly held Lapsed on the fee record Ended Oct 8, 2021 · High confidence | Lapsed on the fee record | Ended Oct 8, 2021 | High confidence |
| US 8,431,588 | Cyclopropyl Polymerase Inhibitors Formerly held Lapsed on the fee record Ended Apr 30, 2021 · High confidence | Lapsed on the fee record | Ended Apr 30, 2021 | High confidence |
| US 8,399,429 | Uracyl Cyclopropyl Nucleotides Lapsed on the fee record Ended Mar 19, 2021 · High confidence | Lapsed on the fee record | Ended Mar 19, 2021 | High confidence |
| US 8,158,779 | Antiviral nucleosides Lapsed on the fee record Ended Apr 17, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2020 | From the USPTO record |
| US 7,935,681 | Antiviral nucleosides Lapsed on the fee record Ended May 3, 2019 · From the USPTO record | Lapsed on the fee record | Ended May 3, 2019 | From the USPTO record |
| US 9,012,428 | Uracyl Spirooxetane Nucleoside Phosphoramidates Formerly held Lapsed on the fee record Ended Apr 21, 2019 · High confidence | Lapsed on the fee record | Ended Apr 21, 2019 | High confidence |
| US 9,006,209 | Uracyl Spirooxetane Nucleoside Phosphoramidates Formerly held Lapsed on the fee record Ended Apr 14, 2019 · Medium confidence | Lapsed on the fee record | Ended Apr 14, 2019 | Medium confidence |